SUBSCRIBE
SUBSCRIBE

Convergent Therapeutics

NEWS
syringe in a vial with a radioactive symbol against a background of antibodies
ADCs
rADCs Could Take Cancer Treatment ‘Magic Bullet’ to a New Level
Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.
October 21, 2024
 · 
6 min read
 · 
Sruthi S. Balakrishnan
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
Convergent Therapeutics Announces Two Clinical Trial Updates on CONV01-α at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025
February 11, 2025
 · 
4 min read
Press Releases
Convergent Therapeutics Appoints Barbara Duncan to Board of Directors
December 11, 2024
 · 
3 min read
Press Releases
Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial
November 19, 2024
 · 
3 min read
Press Releases
Convergent Therapeutics Announces First Patient Treated in Phase II Clinical Trial with Lead Therapeutic Candidate and Corporate Updates
September 24, 2024
 · 
5 min read
Genetown
Convergent Therapeutics Announces FDA Clearance of IND Application for CONV01-α, a Best-in-Class Radioantibody Targeting Prostate-Specific Membrane Antigen
April 2, 2024
 · 
3 min read
Business
Convergent Therapeutics Appoints Scott Myers as Chairman of its Board of Directors
March 4, 2024
 · 
2 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS